## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.6% in mid entry zone (3.0-6.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (3.2%) confirms momentum alignment. Strong momentum (+3.5% 5-day acceleration). Outperforming sector by 3.2%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($155.56)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Federated Hermes Inc. Has $30.86 Million Stock Holdings in Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251210T095245 | Neutral | Relevance: 99%
-  Federated Hermes Inc. significantly reduced its stake in Lam Research Corporation by 46.3% in the second quarter, bringing its total holdings to $30.86 million. Despite this, other institutional investors like Vanguard Group Inc., JPMorgan Chase & Co., and Geode Capital Management LLC increased their positions in the semiconductor company. Wall Street analysts maintain a "Moderate Buy" consensus rating for Lam Research, with a consensus price target of $152.87.

**2. Lam Research (NASDAQ:LRCX) Trading Up 1.9% - Here's Why**
- Source: MarketBeat | 20251209T224021 | Bullish | Relevance: 99%
-  Lam Research (NASDAQ:LRCX) saw its share price increase by 1.9% during mid-day trading on Tuesday, closing at $165.81. This surge comes despite trading volume being 31% below its average daily volume, and follows the company reporting better-than-expected quarterly results with $1.26 EPS and $5.32 billion in revenue. Analysts remain largely positive on LRCX, with a "Moderate Buy" consensus rating, though the average price target is below the current trading price.

**3. Why Lam Research (LRCX) Stock Is Up Today**
- Source: Finviz | 20251208T171515 | Bullish | Relevance: 99%
-  Shares of Lam Research (LRCX) rose after Morgan Stanley increased its price target for the semiconductor equipment maker, citing a 13% increase in its 2027 Wafer Fab Equipment market forecast. The stock's gain aligns with a broader positive trend in the chip-making sector. Lam Research has seen significant growth year-to-date, trading near its 52-week high.

**4. SVB Wealth LLC Acquires Shares of 28,255 Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251209T124742 | Somewhat-Bullish | Relevance: 99%
-  SVB Wealth LLC has acquired 28,255 shares of Lam Research Corporation, valued at approximately $2.75 million, establishing a new position in the semiconductor company. This comes as other institutional investors have also adjusted their holdings, with institutional ownership now standing at around 84.61%. Despite recent insider selling, Lam Research reported a strong quarterly performance, exceeding EPS and revenue expectations, and analysts currently rate the stock as a "Moderate Buy" with an average target price of $152.87.

**5. Lam Research stock hits all-time high at 167.29 USD By Investing.com**
- Source: Investing.com India | 20251210T191233 | Bullish | Relevance: 98%
- Lam Research stock reached an all-time high of $167.29, reflecting a 123.4% increase over the past year and strong investor confidence. The company demonstrates robust fundamentals with a P/E ratio of 36.36 and 25.66% revenue growth, maintaining a "GREAT" financial health score. Analysts have raised price targets, citing strong demand and growth opportunities in the wafer fabrication equipment sector.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $158 | $137 | +15% |
| 2025-11-25 | UBS | $175 | $165 | +6% |
| 2025-11-12 | Citigroup | $190 | $175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Equal-Weight |
| 2025-11-25 | UBS | main | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 6 ($14.07M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $14M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Momentum building: MRS_10 improving +3.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.39 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($14.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $212.2B |
| Beta | 1.78 |
| 52W Range | $56.32 - $169.69 |
| Short Interest | 2.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.39 |
| Forward P/E | 30.1 |
| Current P/E | 34.9 |
| YoY Growth | 15.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 1.1% to 4.6% (+3.5% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 87th percentile. MRS_5 at 3.2% confirms short-term momentum alignment. Outperforming sector by 3.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.28), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.58% (CS: 88) | Strong |
| RSI_14 | 64.6 | Neutral |
| MACD Histogram | 1.28 | Bullish |
| vs SMA20 | 1.091x | Above |
| vs SMA50 | 1.110x | Above |
| vs SMA200 | 1.594x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $168.26
- **Stop Loss:** $155.56 (7.5% risk)
- **Target:** $187.31 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 94
- **Position Value:** $15,816.44
- **Portfolio %:** 15.82%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*